Advertisement

Introduction: Gastrointestinal Stem Cells in Human Health and Disease

  • Maria GazouliEmail author
  • George E. Theodoropoulos
Chapter
Part of the Stem Cell Biology and Regenerative Medicine book series (STEMCELL)

Abstract

The human gastrointestinal tract is a highly compartmentalized structure, lined by a series of specialized epithelial cells. A subset of these cells, called stem cells, are renewed on a periodic basis for purposes of homeostasis preservation and occasional tissue damage repairs. However, these stem cells have been associated with the formation of metaplasia and dysplasia, which are regarded as precancerous lesions. Advances in the characterization of gastrointestinal tract stem cells have offered insight on their establishment, maintenance and regulation. Since deregulation of stem cells may be responsible for premalignant or malignant lesions, a better understanding of the mechanisms responsible for their cellular proliferation, maturation, and differentiation is crucial for these pathologies to be treated.

Keywords

Intestine Regeneration Stem cells Dysplasia Metaplasia Cancer 

References

  1. 1.
    Slack JMW. Metaplasia and transdifferentiation: from pure biology to the clinic. Nat Rev Mol Cell Biol. 2007;8:369–78.CrossRefGoogle Scholar
  2. 2.
    Jaks V, Barker N, Kasper M, et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet. 2008;40:1291–9.CrossRefGoogle Scholar
  3. 3.
    Jung P, Sato T, Merlos-Suárez A, et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med. 2011;17:1225–7.CrossRefGoogle Scholar
  4. 4.
    Forster R, Chiba K, Schaeffer L, et al. Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells. Stem Cell Rep. 2014;2:838–52.CrossRefGoogle Scholar
  5. 5.
    Jeong Y, Rhee H, Martin S, et al. Identification and genetic manipulation of human and mouse oesophageal stem cells. Gut. 2015;309:216–28.Google Scholar
  6. 6.
    DeWard AD, Cramer J, Lagasse E. Cellular heterogeneity in the mouse esophagus implicates the presence of a nonquiescent epithelial stem cell population. Cell Rep. 2014;9:701–11.CrossRefGoogle Scholar
  7. 7.
    Kalabis J, Oyama K, Okawa T, et al. A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. J Clin Invest. 2008;118:3860–9.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Pan Q, Nicholson AM, Barr H, et al. Identification of lineage-uncommitted, long-lived, label-retaining cells in healthy human esophagus and stomach, and in metaplastic esophagus. Gastroenterology. 2013;144:761–70.CrossRefGoogle Scholar
  9. 9.
    Doupe DP, Alcolea MP, Roshan A, et al. A single progenitor population switches behavior to maintain and repair esophageal epithelium. Science. 2012;337:1091–3.CrossRefGoogle Scholar
  10. 10.
    Takashima S, Mkrtchyan M, Younossi-Hartenstein A, et al. The behaviour of Drosophila adult hindgut stem cells is controlled by Wnt and Hh signalling. Nature. 2008;454:651–5.CrossRefGoogle Scholar
  11. 11.
    Cai X, Carlson J, Stoicov C, et al. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology. 2005;128:1937–52.CrossRefGoogle Scholar
  12. 12.
    Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007;133:659–72.CrossRefGoogle Scholar
  13. 13.
    de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter. 2007;12:1–15.PubMedGoogle Scholar
  14. 14.
    Ruge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol. 2000;24:167–76.CrossRefGoogle Scholar
  15. 15.
    Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn’s disease of the colon. Inflamm Bowel Dis. 2009;15:630–8.CrossRefGoogle Scholar
  16. 16.
    Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.CrossRefGoogle Scholar
  17. 17.
    Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.CrossRefGoogle Scholar
  18. 18.
    Mutoh H, Hakamata Y, Sato K, et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun. 2002;294:470–9.CrossRefGoogle Scholar
  19. 19.
    Silberg DG, Sullivan J, Kang E, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 2002;122:689–96.CrossRefGoogle Scholar
  20. 20.
    Silberg DG, Furth EE, Taylor JK, et al. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology. 1997;113:478–86.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Laboratory of Biology, Medical SchoolNational and Kapodistrian University of AthensAthensGreece
  2. 2.First Department of Propaedeutic Surgery, Hippocratio General Hospital, Medical SchoolNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations